ONCAlert | ESMO 2018 Congress
News
Talazoparib Receives FDA Approval in BRCA-Mutated, HER2-Negative Breast Cancer
5:01 PM, Tue October 16, 2018
Benefit From Adjuvant Chemotherapy Seen in Younger Women With Breast Cancer
3:48 PM, Tue October 16, 2018
Use of Tumor-Infiltrating Lymphocytes Expanding in Breast Cancer
1:56 PM, Tue October 16, 2018
Overall Survival Not Improved With Nivolumab in SCLC
6:50 PM, Mon October 15, 2018
Analyzing the Role of Molecular Profiling in Patients With Metastatic Breast Cancer
4:40 PM, Mon October 15, 2018
LOXO-292 Granted FDA's Breakthrough Designation for RET Fusion-Positive Thyroid Cancer
3:26 PM, Mon October 15, 2018
Independent Review Supports Positive Findings With Frontline Lenvatinib in HCC
9:34 PM, Fri October 12, 2018
Grothey Discusses Evolving Treatment Options for Colon Cancer
6:28 PM, Fri October 12, 2018
